Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes: can we stop the time bomb?

M Fisher1

  • 1Glasgow Royal Infirmary, Glasgow G31 2ER, UK. miles.fisher@northglasgow.scot.nhs.uk

Heart (British Cardiac Society)
|April 16, 2003
PubMed
Summary

Type 2 diabetes is rising, increasing cardiovascular disease risk and mortality. Effective management of hyperglycemia and other risk factors can significantly reduce this risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey.

Anaesthesia·1999
Same author

Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.

Nucleic acids research·1999
Same author

Interventional cardiology in people with diabetes.

Diabetic medicine : a journal of the British Diabetic Association·1999
Same author

Neuroprotective effects of a novel broad-spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: a multispectral study.

Journal of magnetic resonance imaging : JMRI·1999
Same author

Transforming growth factor-beta mediates astrocyte-specific regulation of brain endothelial anticoagulant factors.

Stroke·1999
Same author

Endothelin-1 enhances plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-dependent pathway.

Arteriosclerosis, thrombosis, and vascular biology·1999

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Type 2 diabetes prevalence is increasing globally, particularly in the UK.
  • Diabetes significantly elevates the risk of cardiovascular disease (CVD), doubling mortality rates.
  • CVD, including coronary heart disease, is more prevalent and severe in diabetic patients.

Purpose of the Study:

  • To highlight the increased cardiovascular risk in type 2 diabetes patients.
  • To emphasize the importance of managing hyperglycemia and traditional risk factors.
  • To encourage the implementation of established treatment guidelines by healthcare professionals.

Main Methods:

  • Review of large clinical trials and epidemiological data.
  • Analysis of cardiovascular risk factors in type 2 diabetes.
  • Assessment of treatment efficacy for hyperglycemia, hypertension, and hyperlipidemia.

Main Results:

  • Clear evidence exists for cardiovascular risk reduction through managing hyperglycemia.
  • Treatment of traditional risk factors like hypertension and hyperlipidemia is crucial.
  • Diabetic patients face a virtually doubled mortality risk from cardiovascular syndromes.

Conclusions:

  • Implementing treatment guidelines for type 2 diabetes is essential for cardiovascular risk reduction.
  • Healthcare professionals must actively manage hyperglycemia and associated risk factors.
  • Proactive management can mitigate the elevated cardiovascular mortality in diabetic individuals.

Related Experiment Videos